<HashMap><database>biostudies-literature</database><scores/><additional><submitter>Sarfo FS</submitter><funding>National Heart, Lung, and Blood Institute</funding><funding>NHLBI NIH HHS</funding><funding>NINDS NIH HHS</funding><pagination>105401</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC8809888</full_dataset_link><repository>biostudies-literature</repository><omics_type>Unknown</omics_type><volume>29(12)</volume><pubmed_abstract>&lt;h4>Background and purpose&lt;/h4>There are limited data evaluating the characteristics of apparent treatment-resistant hypertension (aTRH) among stroke survivors in sub-Saharan Africa. We aimed to conduct a comparative analysis of the frequency and factors associated with aTRH among stroke survivors and stroke-free individuals with hypertension in Ghana.&lt;h4>Methods&lt;/h4>Cross-sectional multicenter study involving five hospitals in Ghana conducted between July 2015 and June 2018. Clinic-based blood pressure was measured using a standardized protocol and antihypertensive medications assessed via review of medical records and inspection of pills. aTRH was defined as either office BP ≥140/90mmHg on ≥3 classes of antihypertensive medications or on ≥4 antihypertensive medications regardless of BP. </pubmed_abstract><journal>Journal of stroke and cerebrovascular diseases : the official journal of National Stroke Association</journal><pubmed_title>Apparent Treatment Resistant Hypertension Among Stroke Survivors in Ghana.</pubmed_title><pmcid>PMC8809888</pmcid><funding_grant_id>R01 HL152188</funding_grant_id><funding_grant_id>R21 NS103752</funding_grant_id><pubmed_authors>Ovbiagele B</pubmed_authors><pubmed_authors>Sarfo FS</pubmed_authors></additional><is_claimable>false</is_claimable><name>Apparent Treatment Resistant Hypertension Among Stroke Survivors in Ghana.</name><description>&lt;h4>Background and purpose&lt;/h4>There are limited data evaluating the characteristics of apparent treatment-resistant hypertension (aTRH) among stroke survivors in sub-Saharan Africa. We aimed to conduct a comparative analysis of the frequency and factors associated with aTRH among stroke survivors and stroke-free individuals with hypertension in Ghana.&lt;h4>Methods&lt;/h4>Cross-sectional multicenter study involving five hospitals in Ghana conducted between July 2015 and June 2018. Clinic-based blood pressure was measured using a standardized protocol and antihypertensive medications assessed via review of medical records and inspection of pills. aTRH was defined as either office BP ≥140/90mmHg on ≥3 classes of antihypertensive medications or on ≥4 antihypertensive medications regardless of BP. </description><dates><release>2020-01-01T00:00:00Z</release><publication>2020 Dec</publication><modification>2025-04-19T13:19:37.046Z</modification><creation>2025-04-19T13:19:37.046Z</creation></dates><accession>S-EPMC8809888</accession><cross_references><pubmed>33096498</pubmed><doi>10.1016/j.jstrokecerebrovasdis.2020.105401</doi></cross_references></HashMap>